Loading article...
USTR Section 301 report on IP cites concerns over potential threat of patent revocations; pharma sector remains a focus area
The US placed India once again on the priority watch list of countries for alleged deficiencies in its intellectual property (IP) protection and enforcement in the latest USTR Special 301 report on I… [+3135 chars]
Continue reading on BusinessLine
Read Full Article